<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of splenic marginal zone lymphoma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of splenic marginal zone lymphoma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of splenic marginal zone lymphoma</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">CR: complete remission; PR: partial remission.<br/>* Splenectomy is an alternative for patients with localized symptoms due to splenomegaly. Splenectomy is not expected to benefit patients with disseminated nodal involvement outside of the splenic hilum or those with cytopenias due to extensive bone marrow involvement. Splenectomy is preferred for patients with suspected large cell transformation within the spleen. Asplenic patients are at risk for a fulminant sepsis syndrome, usually caused by encapsulated organisms. Whenever elective splenectomy is considered, patients should undergo appropriately timed preoperative immunization.<br/>¶ The following autoimmune complications occur in approximately 20% of cases and require specific management: Autoimmune hemolytic anemia, immune thrombocytopenia, cold agglutinin disease, antiphospholipid antibodies, acquired von Willebrand disease, and acquired C1-esterase inhibitor deficiency.</div><div id="graphicVersion">Graphic 113898 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
